Evidence map›Paper›PMID 36536263›Full record

ArticleTherapeutic innovation & regulatory science2023

A Flexible Ensemble Learning Method for Survival Extrapolation.

Ran Dai, Jihyun Ma, Meijing Wu, Yabing Mai, Weili He

Abstract read
PubMed Publisher
In one paragraph

Article in Therapeutic innovation & regulatory science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ran DaiDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Jihyun MaDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Meijing WuBiostatistics & Statistical Programming, Sanofi US Services Inc., 450 Water Street, Cambridge, MA, 02141, USA. meijing.wu@sanofi.com.
Yabing MaiBiostatistics and Data Sciences TCM, Boehringer Ingelheim, Shanghai, China.
Weili HeData and Statistical Sciences, Abbvie Inc., North Chicago, Illinois, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSurvival extrapolation is an important statistical concept for estimating long-term survival from short-term clinical trial data. It is widely used in health technology assessment (HTA). Survival extrapolation is often performed by fitting one or two parametric models selected based on experience or selecting a model based on some goodness of fit statistics from a predefined collection of models. The main challenge in survival extrapolation is that the result is sensitive to model misspecification. In this study, we aim to propose a new approach that has a robust performance for survival extrapolation.

methodsWe propose a new method called Ensemble Learning for Survival Extrapolation (ELSE). Instead of selecting one best model from a predefined collection, ELSE builds an ensemble model based on a collection of models from the model library. Under this framework, we construct a point estimate of the long-term survival with a weighted average of the estimates of all candidate models and derive confidence intervals using nonparametric bootstrap.

resultsWith our extensive numerical simulation studies, the proposed ELSE method shows better performance than the traditionally used model selection procedure based on Akaike Information Criterion (AIC). With a real data application to the Therapeutically Applicable Research to Generate Effective Treatment Wilms Tumor project (TARGET-WT) data, the ELSE method produces better survival extrapolation results in point estimate accuracy and confidence interval coverage.

conclusionsWe developed an ensemble learning method for survival extrapolation (ELSE) which is robust for the underline data model and has good real data performance.

Indexed as

Machine LearningModels, StatisticalComputer SimulationTreatment OutcomeBootstrapEnsemble learningHealth technology assessmentSurvival analysisSurvival extrapolation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.